Cargando…

The Role of Farnesoid X Receptor in Accelerated Liver Regeneration in Rats Subjected to ALPPS

Background: the role of bile acid (BA)-induced farnesoid X receptor (Fxr) signaling in liver regeneration following associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) was investigated in a rat model. Methods: Male Wistar rats underwent portal vein ligation (PVL) (n =...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daradics, Noemi, Olthof, Pim B., Budai, Andras, Heger, Michal, van Gulik, Thomas M., Fulop, Andras, Szijarto, Attila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700148/ https://www.ncbi.nlm.nih.gov/pubmed/34940077 http://dx.doi.org/10.3390/curroncol28060438

Ejemplares similares

The effect of Cyclophilin D depletion on liver regeneration following associating liver partition and portal vein ligation for staged hepatectomy
por: Daradics, Noemi, et al.
Publicado: (2022)

Case report of actinomycotic liver abscess following COVID-19 infection
por: Lévay, Klára, et al.
Publicado: (2022)

Physical prehabilitation improves the postoperative outcome of associating liver partition and portal vein ligation for staged hepatectomy in experimental model
por: Daradics, Noemi, et al.
Publicado: (2022)

The rush to novelty and high expectations in surgery: the case of ALPPS
por: Olthof, Pim B., et al.
Publicado: (2016)

The use of a NHS-PEG coated, collagen-based sealant in a patient undergoing Associating Liver Partition and Portal vein Ligation for Staged hepatectomy (ALPPS)
por: Olthof, Pim B., et al.
Publicado: (2018)

Demonstration of Metabolic and Cellular Effects of Portal Vein Ligation Using Multi-Modal PET/MRI Measurements in Healthy Rat Liver
por: Fülöp, András, et al.
Publicado: (2014)

Exploration of the Transcriptional Landscape of ALPPS Reveals the Pathways of Accelerated Liver Regeneration
por: Borger, Pieter, et al.
Publicado: (2019)

Mechanism of Liver Regeneration During ALPPS
por: Xiao, Yao, et al.
Publicado: (2022)

Assessment of Liver Function Using (99m)Tc-Mebrofenin Hepatobiliary Scintigraphy in ALPPS (Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy)
por: Cieslak, Kasia P., et al.
Publicado: (2015)

Impact of endothelial nitric oxide synthase activation on accelerated liver regeneration in a rat ALPPS model
por: Masuo, Hitoshi, et al.
Publicado: (2023)

Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration
por: Li, Guodong, et al.
Publicado: (2015)

Experimental evaluation of liver regeneration patterns and liver function following ALPPS
por: Shi, J. H., et al.
Publicado: (2017)

A better route to ALPPS: minimally invasive vs open ALPPS
por: Michal, Kawka, et al.
Publicado: (2020)

Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
por: Wang, Xiaoxin X., et al.
Publicado: (2010)

Comparison of functional and volumetric increase of the future remnant liver and postoperative outcomes after portal vein embolization and complete or partial associating liver partition and portal vein ligation for staged hepatectomy (ALPPS)
por: Rassam, Fadi, et al.
Publicado: (2020)

Partial ALPPS versus complete ALPPS for staged hepatectomy
por: Wu, Xukun, et al.
Publicado: (2019)

Liver growth prediction in ALPPS – A multicenter analysis from the international ALPPS registry
por: Lopez‐Lopez, Victor, et al.
Publicado: (2022)

Rescue ALPPS: Intraoperative Conversion to ALPPS during Synchronous Resection of Rectal Cancer and Liver Metastasis
por: Jackson, Terence, et al.
Publicado: (2014)

Two cases of ALPPS procedure: simultaneous ALPPS and colorectal resection and ALPPS procedure for hepatic malignancy larger than 15 centimeter
por: Choi, Young Il, et al.
Publicado: (2017)

The Farnesoid X Receptor: Good for BAD
por: Keely, Stephen J., et al.
Publicado: (2016)

Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
por: She, Jianglian, et al.
Publicado: (2022)

Farnesoid X receptor (FXR): Structures and ligands
por: Jiang, Longying, et al.
Publicado: (2021)

Unaltered Liver Regeneration in Post-Cholestatic Rats Treated with the FXR Agonist Obeticholic Acid
por: de Haan, Lianne R., et al.
Publicado: (2021)

Levosimendan Administration in Limb Ischemia: Multicomponent Signaling Serving Kidney Protection
por: Onody, Peter, et al.
Publicado: (2016)

ALPPS: PAST, PRESENT AND FUTURE
por: TORRES, Orlando Jorge M, et al.
Publicado: (2015)

Limb remote ischemic conditioning of the recipient protects the liver in a rat model of arterialized orthotopic liver transplantation
por: Czigany, Zoltan, et al.
Publicado: (2018)

Role of farnesoid X receptor and bile acids in alcoholic liver disease
por: Manley, Sharon, et al.
Publicado: (2015)

Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated Platelets
por: Unsworth, Amanda J., et al.
Publicado: (2017)

Loss of Farnesoid X receptor (FXR) accelerates dysregulated glucose and renal injury in db/db mice
por: Qiu, Yuxiang, et al.
Publicado: (2023)

Molecular tuning of farnesoid X receptor partial agonism
por: Merk, Daniel, et al.
Publicado: (2019)

Microbiota-induced obesity requires farnesoid X receptor
por: Parséus, Ava, et al.
Publicado: (2017)

Role of Farnesoid X Receptor in the Pathogenesis of Respiratory Diseases
por: Wu, Jin-nan, et al.
Publicado: (2020)

The Farnesoid X Receptor as a Master Regulator of Hepatotoxicity
por: Rausch, Magdalena, et al.
Publicado: (2022)

ALPPS and the endless pursuit of hepatic resectability
por: Byrne, Matthew, et al.
Publicado: (2022)

Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis
por: LIAN, FAN, et al.
Publicado: (2015)

Noncanonical farnesoid X receptor signaling inhibits apoptosis and impedes liver fibrosis
por: Wang, Hong, et al.
Publicado: (2018)

Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury
por: Petrescu, Anca D., et al.
Publicado: (2021)

Monosegment ALPPS for bilateral colorectal liver metastasis - One is enough
por: Steinbrück, Klaus, et al.
Publicado: (2020)

Assessment of drug–drug interaction potential with EDP‐305, a farnesoid X receptor agonist, in healthy subjects
por: Ahmad, Alaa, et al.
Publicado: (2022)

Levosimendan: A Cardiovascular Drug to Prevent Liver Ischemia-Reperfusion Injury?
por: Onody, Peter, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tlhness8f7qg29irquh7qfrv06